Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China

被引:19
|
作者
Wang, Xiaoli [1 ,2 ,3 ]
Pan, Yang [1 ,2 ,3 ]
Zhang, Daitao [1 ,2 ,3 ]
Chen, Lijuan [1 ,2 ,3 ]
Jia, Lei [1 ,2 ,3 ]
Li, Xinyu [1 ,2 ,3 ]
Yang, Peng [1 ,2 ,3 ]
Wang, Quanyi [1 ,2 ,3 ]
Macintyre, C. Raina [4 ,5 ,6 ]
机构
[1] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China
[2] Beijing Res Ctr Prevent Med, Beijing, Peoples R China
[3] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China
[4] Univ New South Wales, Fac Med, Kirby Inst, Sydney, NSW 2052, Australia
[5] Arizona State Univ, Coll Publ Serv & Community Solut, Tempe, AZ 85281 USA
[6] Arizona State Univ, Coll Hlth Solut, Tempe, AZ 85281 USA
关键词
COVID-19; Epidemiology; Transmissibility; Secondary attack rate; TRANSMISSION; SARS;
D O I
10.1186/s12879-020-05251-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background With the spread of SARS-CoV-2 worldwide, understanding the basic epidemiological parameter values of COVID-19 from real-world data in mega-cities is essential for disease prevention and control. Methods To investigate the epidemiological parameters in SARS-CoV-2 infected cases in Beijing, we studied all confirmed cases and close contacts in Beijing from Jan 1st to Apr 3rd 2020. The epidemiological and virological characteristics of SARS-CoV-2 were analyzed. Results A total of 602 cases were positive for SARS-CoV-2, including 585 confirmed patients and 17 asymptomatic infections. The imported cases were mainly from Wuhan initially and then from abroad. Among 585 confirmed case-patients, the median age was 39 years old. The mean incubation period was 6.3 days. The secondary attack rate among households was higher than social contacts (15.6 vs 4.6%). The secondary attack rate of healthcare workers (HCWs) was higher than non-HCWs' (7.3 vs 4.2%). The basic reproduction number was 2.0, and the average serial interval was 7.6 days. No significant genetic variant was identified. Conclusions The transmissibility of SARS-CoV-2 was relatively high, especially among households and from HCWs, which draws specific public health attention. So far, no evidence of widespread circulation of SARS-CoV-2 in communities in Beijing was found.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] COVID-19 real-world data for the US and lessons to reopen business
    Goldschmidt-Clermont, Pascal J.
    PLOS PATHOGENS, 2020, 16 (08)
  • [12] COVID-19 confidential: Enabling trust in COVID-19 research with fit for purpose real-world data
    Gatto, Nicolle M.
    Franklin, Jessica
    Garry, Elizabeth M.
    Martin, David
    Chakravarty, Aloka
    Rassen, Jeremy A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 6 - 6
  • [13] CHARACTERISTICS AND OUTCOMES IN A REAL-WORLD COHORT OF RHEUMATOID ARTHRITIS PATIENTS WITH COVID-19
    Ye, Y.
    Yue, X.
    Krueger, W.
    Wegrzyn, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 860 - 860
  • [14] Tracing Management and Epidemiological Characteristics of COVID-19 Close Contacts in Cities Around Chengdu, China
    Yang, Kai
    Deng, Jiali
    Wang, Liang
    Jiang, Shan
    Lu, Rong
    Liu, Zhijian
    Tuo, Xiaoli
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [15] Sex differences in comorbidities and COVID-19 mortality-Report from the real-world data
    Yoshida, Yilin
    Wang, Jia
    Zu, Yuanhao
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [16] Antithrombotic Use Patterns in COVID-19 Patients from Spain: A Real-World Data Study
    Ramirez-Cervantes, Karen Lizzette
    Campillo-Morales, Salvador
    Garcia-Poza, Patricia
    Quintana-Diaz, Manuel
    Huerta-Alvarez, Consuelo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [17] COVID-19 in Adults with Sickle Cell Disease: Data from Cerner Real-World Database
    Guarino, Stephanie H.
    Gbadebo, Bayo
    Caplan, Richard
    Ndura, Kevin
    Jurkovitz, Claudine
    BLOOD, 2022, 140 : 13172 - 13173
  • [18] REAL-WORLD EFFECTIVENESS OF EARLY TREATMENTS FOR COVID-19: EVIDENCE FROM ADMINISTRATIVE CLAIMS DATA
    Bell, C.
    Lokhandwala, T.
    Gibbons, D.
    Patel, V
    Drysdale, M.
    Wang, J.
    Lloyd, E.
    VALUE IN HEALTH, 2023, 26 (06) : S24 - S24
  • [19] COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
    Kherabi, Yousra
    Launay, Odile
    Liem Binh Luong Nguyen
    VIRUSES-BASEL, 2022, 14 (10):
  • [20] Effectiveness of COVID-19 vaccines: findings from real-world studies
    Henry, David A.
    Jones, Mark A.
    Stehlik, Paulina
    Glasziou, Paul P.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 216 (08) : 431 - 431